Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Guidelines published on long-term use of NSAIDs in cats
The first version of the consensus guidelines was published in 2010.
ISFM and AAFP release new version of their consensus guidelines.

An updated consensus guidelines for the long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) in cats with chronic pain has been published.

Created by the International Society of Feline Medicine (ISFM) and the American Association of Feline Practitioners (AAFP), the guidelines are designed to support veterinary surgeons with making decisions about prescribing NSAIDs long-term to optimise pain management and minimise adverse effects.

The guidelines include information on assessing patient suitability, considerations to take into account when there are comorbidities present, and how to monitor treatment efficacy.

Alongside the guidelines, the ISFM has created three new guides for owners whose cats have been prescribed NSAIDs: ‘Treating chronic (long-lasting) pain with NSAIDs’, ‘Changes to the home environment for cats with muscle/joint pain or mobility problems’ and ‘Encouraging your cat to drink’. AAFP has also produced a client brochure: ‘Treating chronic pain with NSAIDs’, which goes alongside the guidelines.

ISFM and AAFP published the first version of their NSAID guidelines in 2010. The latest version has been informed by multiple studies into the use of NSAIDs in cats, many with a focus on cats with comorbidities, which have been published since then.

Heather O’Steen, AAFP chief executive, said: “We are thrilled to announce the release of these new guidelines addressing long-term use of NSAIDs in cats.

With a focus on safety, efficacy, and responsible medication management, these guidelines aim to enhance the quality of life for cats while minimising potential risks. We believe that these guidelines will serve as a vital resource in ensuring the optimal care and wellbeing of cats receiving long-term NSAID therapy.”

The ‘2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats’ has been published in the Journal of Feline Medicine and Surgery.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.